FCGR3A and neoplasm: We also utilized this strategy to enhance the functional capabilities of CD38KO NK cells by inserting a FLAG-tagged CD16-158V receptor, which resulted in detectable FLAG expression in approximately 57% of CD38KO NK cells that had increased DARA-mediated ADCC against MM tumor targets.